A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity ...

There's a lot going on in the teeming microbiomes of our guts, and we're regularly making new discoveries about these ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...